Published in Br Med J on February 10, 1945
The histotoxic clostridial infections of man. Bacteriol Rev (1962) 4.06
THE RENAL CIRCULATION IN SHOCK. J Clin Invest (1944) 9.42
Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev (1998) 2.28
COMPLETE AURICULO-VENTRICULAR DISSOCIATION WITH HIGH VENTRICULAR RATE IN PAROXYSMAL TACHYCARDIA. Br Heart J (1943) 1.34
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies. Neurosci Biobehav Rev (1997) 1.27
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett (2001) 1.20
Haemodynamic effects of balloon septostomy in tricuspid atresia. Br Med J (1968) 1.10
Pulmonary artery banding and subsequent repair in ventricular septal defect. Br Heart J (1973) 1.08
The role of N-methylaspartate receptors in mediating responses of rat and cat spinal neurones to defined sensory stimuli. J Physiol (1987) 1.08
Pharmacodynamics of memantine: an update. Curr Neuropharmacol (2008) 1.03
Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol (1996) 0.98
Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br J Pharmacol (1996) 0.98
Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology (1997) 0.97
Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. Eur J Neurosci (2003) 0.97
Transposition of great arteries. A study of 65 infants followed for 1 to 4 years after balloon septostomy. Br Heart J (1971) 0.96
Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats. Eur J Neurosci (1996) 0.96
Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices. Neuropharmacology (1999) 0.95
Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity. Neuropharmacology (1995) 0.94
Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action. Neurotox Res (2000) 0.92
Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication. J Neural Transm (Vienna) (1999) 0.89
Learning deficits induced by chronic intraventricular infusion of quinolinic acid--protection by MK-801 and memantine. Eur J Pharmacol (1996) 0.88
Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones. Neuropharmacology (1999) 0.87
Comparison of mu, kappa and sigma preferring agonists for effects on spinal nociceptive and other responses in rats. Neuropeptides (1984) 0.86
Recurrence of aortic coarctation after operation in childhood. Br Med J (1966) 0.86
Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats. Br J Pharmacol (1991) 0.85
GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids (1998) 0.85
Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp. Neuropharmacology (1997) 0.84
Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine. Neuropharmacology (2007) 0.84
Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex. Nucl Med Biol (1998) 0.83
Synthesis and structure-affinity relationships of 1,3, 5-alkylsubstituted cyclohexylamines binding at NMDA receptor PCP site. Eur J Med Chem (2000) 0.82
Amino-alkyl-cyclohexanes as a novel class of uncompetitive NMDA receptor antagonists. Curr Pharm Des (2002) 0.82
Expression of early hippocampal CA1 LTP does not lead to changes in AMPA-EPSC kinetics or sensitivity to cyclothiazide. Pflugers Arch (1999) 0.82
Recurrent coarctation of the aorta. Am Heart J (1967) 0.81
Memantine selectively depresses NMDA receptor-mediated responses of ratspinal neurones in vivo. Neurosci Lett (1994) 0.80
NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization. Amino Acids (2000) 0.80
Autoradiographic and electrophysiological evidence for excitatory amino acid transmission in the periaqueductal gray projection to nucleus raphe magnus in the rat. Neurosci Lett (1988) 0.80
Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices. Neuropharmacology (2000) 0.80
Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. Br J Pharmacol (1996) 0.80
Anomalous left coronary artery. Report of an unusual case with spontaneous remission of symptoms. Br Heart J (1973) 0.79
Brain distribution of an uncompetitive NMDA receptor antagonist; comparison to its in vitro potency in electrophysiological studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.78
Chronic treatment with the uncompetitive NMDA receptor antagonist memantine influences the polyamine and glycine binding sites of the NMDA receptor complex in aged rats. J Neural Transm Park Dis Dement Sect (1995) 0.78
The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones. Neuropharmacology (2001) 0.77
Zinc changes AMPA receptor properties: results of binding studies and patch clamp recordings. Neuropharmacology (1996) 0.77
Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studies. J Neural Transm Gen Sect (1995) 0.77
The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole. J Neural Transm (Vienna) (2008) 0.77
Protection against post-ischaemic neuronal loss in gerbil hippocampal CA1 by glycineB and AMPA antagonists. Short communication. J Neural Transm (Vienna) (1997) 0.76
Do kappa opioids mimic sigma agonists as amino acid antagonists? Neuropharmacology (1986) 0.76
A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization. J Neural Transm (Vienna) (2007) 0.76
Congenital mitral stenosis. Br Heart J (1967) 0.75
GlycineB recognition site of NMDA receptors and its antagonists. Amino Acids (1998) 0.75
The Treatment of Acute Leukaemia in Adults with Cyclophosphamide. Postgrad Med J (1965) 0.75
Transposition of the great arteries. A review of 37 cases after Mustard's operation. Thorax (1973) 0.75
Fluorine-18 radiolabelling, biodistribution studies and preliminary PET evaluation of a new memantine derivative for imaging the NMDA receptor. J Recept Signal Transduct Res (1999) 0.75
Twelve years follow-up after surgical correction of Fallot's tetralogy in childhood. Br Heart J (1972) 0.75
Local opioid receptors mediating antinociception in inflammation: endogenous ligands. Prog Clin Biol Res (1990) 0.75
Reflex Action During General Surgical Anaesthesia. Ann Surg (1913) 0.75
Preparation for retirement. Practitioner (1978) 0.75
A novel series of 2-carboxytetrahydroquinolines provides new insights into the eastern region of glycine site NMDA antagonists. Arch Pharm (Weinheim) (2000) 0.75
Stomatitis in Childhood. Arch Dis Child (1940) 0.75
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats. Pain (2001) 0.75